Allied Market Research published a report, titled, “Immunoassay Market by Product (Reagents and Kits and Analyzers), Technology (ELISA, Chemiluminescence Immunoassay, Immunofluorescence assay, Rapid Test, ELISpot, Western Blotting and Others), Specimen (Infectious Diseases, Endocrinology, Oncology, Bone and Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening and Others), and End user (Hospitals and Clinics, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Blood Banks, Research and Academic Laboratories and Home Care Settings) : Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the immunoassay market was valued at $35.0 billion in 2023, and is estimated to reach $61.6 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033.
Key Drivers:
Rising Disease Prevalence: An increase in chronic and infectious diseases necessitates advanced diagnostic tools.
Technological Advancements: Innovations such as miniaturized, automated ELISA devices are enhancing the efficiency and accessibility of immunoassays.
Shift to POC Testing: The demand for rapid, on-site diagnostic solutions is propelling the adoption of POC immunoassays.
Emerging Technologies & Innovations
Miniaturized ELISA Devices: Recent developments include compact, automated ELISA devices that are cost-effective and suitable for POC applications.
- Integration with Digital Health: The incorporation of immunoassays with wearable devices and smartphone-based platforms is enhancing real-time health monitoring and diagnostics.
Request Sample of the Report on – https://www.alliedmarketresearch.com/request-sample/939
Rise in incidences of chronic diseases, favorable regulatory scenario, and increase in geriatric population are the major factors that drive the growth of the immunoassay market growth. However, high development and manufacturing costs hinder market growth. Moreover, technological advancements and untapped markets in developing economies offer remunerative opportunities for the expansion of the global immunoassay market.
Segment Highlights
By technology
The enzyme-Linked Immunosorbent Assay (ELISA) segment generated the highest revenue in the immunoassay market in 2023. The high sensitivity, specificity, and versatility of Enzyme-Linked Immunosorbent Assay (ELISA) , making it suitable for various applications. ELISA is valuable in medical diagnostics, research, and drug development due to its high sensitivity, specificity, and scalability. It plays a crucial role in diagnosing diseases, monitoring biomarkers, and evaluating immune responses, contributing to advancements in healthcare and biomedical research.
By specimen
The blood specimens segment generated the highest revenue in the immunoassay market in 2023. Blood specimens are widely used in immunoassays due to their accessibility, abundance of biomarkers, and ability to provide valuable insights into various diseases and conditions. Blood-based immunoassays enable the detection and quantification of specific analytes, such as proteins, antibodies, and hormones, facilitating disease diagnosis, prognosis, and monitoring.
By end user
Hospitals and clinics widely utilize immunoassay technology due to its versatility, accuracy, and rapid results. Immunoassays enable healthcare providers to perform a wide range of diagnostic tests, including disease screening, monitoring, and prognosis, enhancing patient care and treatment decision-making within clinical settings.
Regional Outlook
In North America there is a robust market for immunoassay due to advanced healthcare systems, rise in prevalence of chronic disease conditions, and greater accessibility to healthcare services. These regions also witness significant research and development activities, leading to the advancement in immunoassay technology. In emerging markets such as Asia-Pacific and LAMEA the immunoassay market is experiencing rapid growth driven by increasing healthcare expenditure and expanding pharmaceutical industries.
Key Players
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Abbott Laboratories
- Siemens Healthineers (Siemens AG)
- DiaSorin S.p.A.
- Sysmex Corporation
- BioMerieux SA
- Ortho Clinical Diagnostics
- Thermo Fisher Scientific, Inc.,
- Becton, Dickinson and Company
- Merck kGaA
Recent Industry Development
- In April 2021, Roche Diagnostics received CE mark certification for its Elecsys anti-p53 immunoassay, a test used to diagnose various types of cancer. The Elecsys test is used for the in vitro quantitative determination of anti-p53 antibodies in patients to aid physicians in diagnosis of esophageal cancer, bowel cancer and breast cancer
- In December 2023, Sysmex Corporation, announced that following their introduction in Japan and the United States, its reagents used for blood testing to identify Amyloid Beta (Aβ) accumulation in the brain—will be expanded to Europe starting January 2024. Sysmex will continue to promote activities towards expanding its testing parameters, including the assay kits, and accelerating the deployment of immunochemistry testing business in Europe.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2023?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2033?
- Which region has more opportunities?
You may Also Like
Serum Free and Specialty Media Market is Growing at a CAGR of 11.6% from 2024 to 2033
Homeopathy Market Size, Share | Trends Report 2033
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
